Skip to content
Thursday 13 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,772.67
-0.56%
DAX
26,299.74
-0.12%
CAC 40
8,650.56
-0.28%
STOXX 50
6,545.47
+0.18%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE

Astrazeneca

  • Covid-19 global pandemic to be ‘regional epidemic’ by next year, says AstraZeneca boss

    November 23, 2021

    AstraZeneca boss Pascal Soriot said that he expects the global Covid-19 pandemic to become a regional epidemic by next year, after the pharmaceutical giant decided to start profiting from its vaccine. The chief executive of the pharmaceutical giant told Sky News that by 2022, “essentially most of the world at that point will be in [...]

  • AstraZeneca sales jump 50 per cent as vaccine crawls to profitability

    November 12, 2021

    AstraZeneca’s revenues have soared 32 per cent this year to $25.4bn, powered by booming product sales. Third quarter revenues are up 50 per cent, with the pharmaceutical giant enjoying a $9.87 billion increase in revenues over the three-month period. The company has sold 2.2 billion vaccines since the start of the year. It has now [...]

  • AstraZeneca says new Coronavirus antibody treatment can prevent as well as cure Covid-19

    October 11, 2021

    AstraZeneca said in a filing this morning that a new antibody treatment the British pharma giant has developed has the ability to prevent as well as treat Covid-19. The company has filed a request to the US Food and Drug Administration (FDA) last week for emergency use authorisation for AZD7442, which is made up of [...]

  • Oxford-AstraZeneca vaccine creator to make keynote speech at UK’s Global Investment Summit

    October 11, 2021

    The UK’s pharmaceutical industry is set to take top billing at the UK’s Global Investment Summit next week, with GlaxoSmithKline’s chief executive and one of the creator’s of the Oxford-AstraZeneca vaccine to deliver keynote speeches. GSK chief Dame Emma Walmsley and Oxford University vaccinologist Sarah Gilbert will be alongside World Trade Organisation (WTO) director-general Dr [...]

  • Your third Covid shot is coming: All you need to know about booster vaccines

    October 3, 2021

    It seems inevitable: a third Covid shot is coming your way this Autumn. Two jabs may not give us sufficient protection, or at least not in the long term. Booster jabs are being offered as part of a ramped-up vaccine campaign in England. Some 1.5 million people will be contacted and encouraged to use the [...]

  • EU vs Astrazeneca: Vaccine legal battle over as UK pharma pledges jab deliveries

    September 3, 2021

    The legal stand-off between the European Union (EU) and FTSE-listed Covid-19 vaccine maker Astrazeneca appears to be over. Astrazeneca and the European Commission have reached a settlement on the delivery of 200m vaccine doses still to be delivered by the drug com[any, ending a row about shortages that had heightened reputational damage on Astra and weighed [...]

  • Fatal blood clot: Coroner rules AstraZeneca vaccine caused death of BBC host Lisa Shaw

    August 27, 2021

    The death of award-winning BBC radio presenter Lisa Shaw was caused by complications as a result of the AstraZeneca Covid-19 vaccine, a coroner in Newcastle has concluded. Shaw died in May, just over three weeks after she had her first dose of the jab, an inquest in Newcastle heard on Thursday. The 44-year-old – who [...]

  • Astrazeneca’s non-vaccine therapy cuts chance of getting symptomatic Covid by 77 per cent, trial finds

    August 20, 2021

    FTSE-listed Astrazeneca this morning said its Covid-19 antibody therapy met the main goal of preventing coronavirus symptoms in a late-stage study. It means the Anglo-Swedish pharma is on track to potentially offer an alternative to vaccines for people with weakened immune systems. Astrazeneca said it will now submit data to try and get emergency authorisation [...]

  • Who’s Who: Top ten earning FTSE 100 CEOs take home £89.5m

    August 19, 2021

    A new report has revealed that the top ten earning FTSE 100 CEOs took home £89.5m between them in 2020. Pascal Soriot, the chief executive of AstraZeneca, topped the list taking home a healthy paycheck of £15.45m. The report, published by the High Pay Centre, noted that Soriot’s earnings were well above the average pay [...]

  • Barbie doll created of Oxford Covid vaccine designer Dame Sarah Gilbert

    August 4, 2021

    Barbie maker Mattel has created a doll in honour of Professor Dame Sarah Gilbert, the scientist who designed the Oxford-Astrazeneca Covid vaccine. After a standing ovation at Wimbledon and being made a dame, Gilbert now has the Barbie doll to recognise her efforts in creating a life-saving jab. The vaccinologist said she initially found the [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Page 27
  • Next

Trending Articles

  • Five-star Mayfair hotel hit with HMRC winding-up petition

  • It’s not just Jason Arday, most of sociology is a scam

  • IT consultant ordered to pay £50,000 after being accused of stealing Soho House members’ personal details

  • Revolut takes flight with launch of new airport lounges

  • As it happened: FTSE 100 falls as Iran and US clash over Strait of Hormuz; Oil stockpiles ‘rapidly depleting’

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook